secwatch.observer — SEC 8-K summary
======================================

Issuer:     Context Therapeutics Inc. (CNTX)
CIK:        0001842952
Form:       8-K
Filed at:   2021-11-01T23:59:59+00:00
Accession:  0001842952-21-000005
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Context Therapeutics appoints Jennifer Minai-Azary as CFO with $365K base salary
--------------------------------------------------------------------------------

- Jennifer Minai-Azary appointed CFO; previously CFO at Millendo Therapeutics, led merger with Tempest.
- Employment agreement: $365,000 annual base salary; target annual bonus of 40% of base salary.
- Granted non-qualified stock options for 52,753 shares, vesting monthly over 3 years.
- Severance: 9 months base salary if terminated without cause; change-in-control triggers 12 months salary plus full equity vesting.
- Press release also notes Alex Levit was appointed Chief Legal Officer in April 2021.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1842952/000184295221000005/0001842952-21-000005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1842952/000184295221000005/cntx-20211101.htm
  HTML page:      https://secwatch.observer/filing/0001842952-21-000005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer